Published in Scand J Urol Nephrol on January 01, 1985
Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev (1991) 7.11
The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci U S A (1994) 3.02
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells. Infect Immun (1987) 1.41
Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol (2005) 1.17
Characterisation of Escherichia coli adhesins in patients with symptomatic urinary tract infections. Genitourin Med (1989) 0.78
Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med (2001) 10.56
Lipopolysaccharide heterogeneity in Salmonella typhimurium analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis. Eur J Biochem (1980) 8.05
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63
Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun (1981) 5.24
New Method for isolation of immunologically pure pili from Escherichia coli. Infect Immun (1980) 4.98
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun (1985) 4.01
F + , Hfr, and F' strains of Salmonella typhimurium and Salmonella abony. Bacteriol Rev (1972) 3.73
Occurrence of P-fimbriated Escherichia coli in urinary tract infections. Lancet (1982) 3.64
Genetic relationships and clonal structure of strains of Escherichia coli causing neonatal septicemia and meningitis. Infect Immun (1986) 3.57
P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun (1984) 3.50
Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis. Lancet (1982) 3.39
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37
Escherichia coli fimbriae recognizing sialyl galactosides. J Bacteriol (1984) 3.16
Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol (2001) 3.12
P-antigen-recognizing fimbriae from human uropathogenic Escherichia coli strains. Infect Immun (1982) 3.02
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
Escherichia coli strains binding neuraminyl alpha 2-3 galactosides. Biochem Biophys Res Commun (1983) 2.87
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83
Bacterial proteins binding to the mammalian extracellular matrix. Mol Microbiol (1993) 2.81
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli. Lancet (1982) 2.56
Immunization with major outer membrane proteins in experimental salmonellosis of mice. Infect Immun (1979) 2.53
Effect of polymyxin on the ultrastructure of the outer membrane of wild-type and polymyxin-resistant strain of Salmonella. J Bacteriol (1976) 2.43
Enterobacterial common antigen. Bacteriol Rev (1976) 2.41
Clinical pyelonephritis and focal renal scarring. A selected review of pathogenesis, prevention, and prognosis. Pediatr Clin North Am (1982) 2.33
Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals. Infect Immun (1986) 2.27
Evolution and clonal traits of Mycobacterium tuberculosis complex in Guinea-Bissau. J Clin Microbiol (1999) 2.23
The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science (1983) 2.22
Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium. Infect Immun (1979) 2.21
Bacterial plasminogen activators and receptors. FEMS Microbiol Rev (2001) 2.19
Epidemic outbreaks of acute pyelonephritis caused by nosocomial spread of P fimbriated Escherichia coli in children. J Infect Dis (1984) 2.19
Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis (1996) 2.15
Hydrophobic domains affect the collagen-binding specificity and surface polymerization as well as the virulence potential of the YadA protein of Yersinia enterocolitica. Mol Microbiol (1993) 2.13
Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71. J Bacteriol (1984) 2.11
Aspects on structure and function of pili on uropathogenic Escherichia coli. Prog Allergy (1983) 2.11
Rapid diagnosis of tuberculosis by detection of mycobacterial lipoarabinomannan in urine. J Microbiol Methods (2001) 2.07
Bacteriophage-resistant mutants of Salmonella typhimurium deficient in two major outer membrane proteins. J Bacteriol (1976) 2.02
Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet (1975) 1.97
Type V collagen as the target for type-3 fimbriae, enterobacterial adherence organelles. Mol Microbiol (1990) 1.94
Characterization of type 1 pili of Salmonella typhimurium LT2. J Bacteriol (1980) 1.94
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91
Risk factors for pneumonia in the elderly. Am J Med (1994) 1.89
Rapid identification of P-fimbriated Escherichia coli by a receptor-specific particle agglutination test. Infection (1982) 1.88
The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol (1989) 1.87
The role of IFN-gamma in murine Salmonella typhimurium infection. Microb Pathog (1990) 1.84
Binding sites in the rat brain for Escherichia coli S fimbriae associated with neonatal meningitis. J Clin Invest (1988) 1.82
Genetic determination of the O antigens of Salmonella groups B (4,5,12) and C1(6,7). J Bacteriol (1966) 1.81
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Type 3 fimbriae of Klebsiella sp.: molecular characterization and role in bacterial adhesion to plant roots. J Bacteriol (1983) 1.79
Inheritance of the O antigens of Salmonella groups B and D. J Gen Microbiol (1965) 1.79
Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. Infect Immun (1998) 1.76
New Salmonella typhimurium mutants with altered outer membrane permeability. J Bacteriol (1984) 1.76
Identification of two new hemagglutinins of Escherichia coli, N-acetyl-D-glucosamine-specific fimbriae and a blood group M-specific agglutinin, by cloning the corresponding genes in Escherichia coli K-12. J Bacteriol (1986) 1.74
Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium. Eur J Clin Microbiol (1987) 1.72
Cleavage of the polysialosyl units of brain glycoproteins by a bacteriophage endosialidase. Involvement of a long oligosaccharide segment in molecular interactions of polysialic acid. J Biol Chem (1985) 1.71
Location of adhesion sites for P-fimbriated and for 075X-positive Escherichia coli in the human kidney. Microb Pathog (1986) 1.69
Binding specificity of piliated strains of Escherichia coli and Salmonella typhimurium to epithelial cells, saccharomyces cerevisiae cells, and erythrocytes. Infect Immun (1981) 1.68
A novel virulence-associated cell surface structure composed of 47-kd protein subunits in Yersinia enterocolitica. EMBO J (1985) 1.68
Identification of a carbohydrate receptor recognized by uropathogenic Escherichia coli. Infection (1980) 1.66
Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol Microbiol (1993) 1.66
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65
Genetic aspects of biosynthesis and structure of Salmonella somatic polysaccharide. Ann N Y Acad Sci (1966) 1.64
Carbohydrate receptor structures recognized by uropathogenic E. coli. Scand J Infect Dis Suppl (1982) 1.63
An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action. J Immunol (1984) 1.62
Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections. Infect Immun (1986) 1.60
Mutants defective in the 33K outer membrane protein of Salmonella typhimurium. J Bacteriol (1979) 1.60
The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis (1981) 1.59
Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J (1998) 1.59
Genetic determination of enzymes synthesizing O-specific sugars of Salmonella lipopolysaccharides. J Bacteriol (1966) 1.58
P-fimbriae of pyelonephritogenic Escherichia coli: identification and chemical characterization of receptors. Infection (1983) 1.57
Role of O-antigen (lipopolysaccharide) factors in the virulence of Salmonella. J Infect Dis (1973) 1.57
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Binding characteristics of Escherichia coli adhesins in human urinary bladder. Infect Immun (1988) 1.53
Occurrence of type-1C fimbriae on Escherichia coli strains isolated from human extraintestinal infections. J Gen Microbiol (1985) 1.53
Coupling of acid labile Salmonella specific oligosaccharides to macromolecular carriers. J Immunol Methods (1979) 1.52
Participation of lipopolysaccharide genes in the determination of the enterobacterial common antigen: analysis of R mutants of Salmonella minnesota. J Bacteriol (1974) 1.52
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med (1997) 1.50
Analysis of the genetic determinants coding for the S-fimbrial adhesin (sfa) in different Escherichia coli strains causing meningitis or urinary tract infections. Infect Immun (1986) 1.48
Protein K: a new major outer membrane protein found in encapsulated Escherichia coli. J Bacteriol (1979) 1.47